Alpaca antibodies can destroy the new crown what exactly?

According to British media reports, U.S. experts say antibodies to the New Crown virus, made through alpacas, could be used to treat New Crown disease.

Nanobodies are produced naturally by the immune system of camels, and a family of camelids such as alpacas and alpacas produce nanobodies. Nanobodies are smaller and easier to engineer than human antibodies. At the same time, the nano-antibodies will also adhere to the spiny protein of SARS-CoV-2, the virus that causes the new crown disease, and the nano-antibodies can effectively neutralize it. British experts say that nano-antibodies made by animal immune systems are far more effective than human antibodies in treating and preventing New Crown disease.

Researchers at the U.S. National Institutes of Health (NIH) have reportedly isolated these nano-antibodies from an alpaca named Cormac to test their "therapeutic, preventive, and diagnostic potential" in the fight against the new crown virus. ". Early findings suggest that the nanobodies could be given in aerosol form, as a nasal spray or asthma-type inhaler, to patients with neoguana to treat neoguana disease.

Cormack was given five injections over 28 days of a harmless, laboratory-developed "pseudo-neocoronavirus," which has the same spiny protein as SARS-CoV-2. The "pseudo-neo-coronavirus" activated Cormac's immune system, which then produced nano-antibodies. These nanobodies try to cover the spiny protein, thus preventing it from binding to the ACE2 receptor. The researchers found that low levels of NIH-CoVnb-112 nanobodies prevented Pseudorabies virus from infecting healthy cells in a petri dish. Although we still have a lot of work to do, these results represent a promising first step," says Esparza. With support from the National Institutes of Health, we are moving forward rapidly to test whether these nanobodies can be a safe and effective preventive treatment for the new crown disease."

Professor Brody said, "One of the exciting things about nano-antibodies is that, unlike most conventional antibodies, they can be nebulized and inhaled to cover the lungs and respiratory tract." Early findings suggest that nano-antibodies could be given to patients with NeoCrown in the form of an aerosol, made into a nasal spray or an asthma-type inhaler, to treat NeoCrown disease.

Neuroscientists at the National Institutes of Health have now filed a patent for the nanobodies. Meanwhile, the University of Reading in Zhenling Hill, Malaysia, is also conducting such research. The university institute houses a herd of alpacas, cared for by specialized staff, which will provide nano-antibodies that can be used in clinical trials of potential drugs.